Aprea Therapeutics, Inc. (APRE)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
APRE Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
APRE Quarterly Cost of Revenue ($0.00 → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
APRE cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 5,428 | |
| 0 | |
| 0 | |
| 1,912,213 | |
| 2,483,066 | |
| 2,359,086 | |
| 2,846,399 | |
| 2,557,679 | |
| 1,600,373 | |
| 2,045,688 | |
| 2,122,603 | |
| 2,202,657 | |
| 1,256,542 | |
| 531,406 | |
| 1,117,576 | |
| 6,811,609 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |